Investor
Relations

We are committed to developing transformational biologic medicines to serve patients with debilitating diseases

Committee Composition

	Independent Director	Audit Committee	Compensation Committee	Nominating and Corporate Governance Committee
Charlene Banard	Independent Director	Audit Committee	Compensation Committee
Holly Schachner, M.D.	Independent Director		Compensation Committee	Nominating and Corporate Governance Committee
John Smither	Independent Director	Audit Committee	Compensation Committee
Aaron VanDevender	Independent Director	Audit Committee		Nominating and Corporate Governance Committee

= Executive Chair = Lead Independent Director = Independent Director = Chairperson = Member = Lead Director